Pharmaceutical

Swiss biotech sector’s R&D investment grew in 2024 despite global trends

Research and development (R&D) investment in the Swiss biotech sector grew in 2024, despite ongoing global funding struggles.

May 6, 2025 - 06:00
Swiss biotech sector’s R&D investment grew in 2024 despite global trends
Research and development (R&D) investment in the Swiss biotech sector grew in 2024, despite ongoing global funding struggles.
Read the original article

Tags:

Previous Article

Diagnosing and Treating Rare Genetic Disorders Now

Next Article

FDA approves Selarsdi injection as interchangeable with Stelara

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Vertex secures FDA clearance for infants’ cystic fibrosis therapy

Vertex secures FDA clearance for infants’ cystic fibros...

May 4, 2023

Attralus set for amyloidosis asset’s European orphan designations

Attralus set for amyloidosis asset’s European orphan de...

Jul 30, 2024

Opinion: STAT+: How to make the EU’s new Joint Clinical Assessment process work for industry — and for patients

Opinion: STAT+: How to make the EU’s new Joint Clinical...

Oct 20, 2023